← Back to Search

Gait-cognitive training for Parkinson's Disease

N/A

Waitlist Available

Led By Lisa M Muratori

Research Sponsored by Stony Brook University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (day one); week 4-5 (immediate post 4 week training program); 5-6 weeks (one-week post-training); 9-10 weeks (one month post-training)

Awards & highlights

Study Summary

This trial will study how Parkinson's disease affects walking, and how adding a cognitive task affects walking.

Eligible Conditions

Parkinson's Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (day one); week 4-5 (immediate post 4 week training program); 5-6 weeks (one-week post-training); 9-10 weeks (one month post-training)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (day one); week 4-5 (immediate post 4 week training program); 5-6 weeks (one-week post-training); 9-10 weeks (one month post-training)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (day one); week 4-5 (immediate post 4 week training program); 5-6 weeks (one-week post-training); 9-10 weeks (one month post-training) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Spatiotemporal measures of gait across conditions and over time.

Secondary outcome measures

Changes in cognitive performance measured with serial sevens.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Identification of at risk variablesExperimental Treatment1 Intervention

Individuals will come in for a single visit to perform all tasks / conditions. Measurements will be taken of spatial and temporal features of walking with and without a secondary task. In addition, cognitive tests of memory and attention will be performed. Outcomes will narrow measures to those most likely to show clinically significant change.

Group II: Gait-Cognitive trainingExperimental Treatment1 Intervention

Participants will engage in a four week treadmill training program with a secondary cognitive component aimed at improving both walking and multitasking.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor

213 Previous Clinical Trials

39,503 Total Patients Enrolled

Lisa M MuratoriPrincipal InvestigatorStony Brook University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age cap for enrolment into this research trial?

"This medical trial welcomes patients aged 21 and above, but not exceeding 80 years."

Answered by AI

Is enrollment for this experiment currently available?

"According to the record on clinicaltrials.gov, this research endeavour is no longer seeking participants after being initially posted on October 26th 2020 and last updated January 14th 2022. Luckily, there are 488 other trials offering entry at present."

Answered by AI

Who qualifies for enrollment in this clinical trial?

"This trial is looking for 24 patients, aged 21-80 years old, with clinical diagnoses of Parkinson's disease and the capacity to walk 200 feet independent of assistive devices like canes or walkers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cognitive-motor Training for PD

Lisa Muratori 2020. "Cognitive-motor Training for PD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01917903.